New Schizophrenia Drug Shows Promise in Trials - New York Times

New Schizophrenia Drug Shows Promise in Trials - New York Times: "New Schizophrenia Drug Shows Promise in Trials "

In a clinical trial of about 200 patients, an experimental drug from Eli Lilly lessened schizophrenia symptoms without the serious side effects of current treatments, according to a paper published Sunday in the journal Nature.
The drug must still be tested on many more patients and is at least three to four years from completing regulatory review. But schizophrenia researchers said the trial’s results were surprising and impressive, especially since the drug works in a different way from existing antipsychotic medicines, all of which have serious side effects including weight gain and tremors